215 related articles for article (PubMed ID: 20581016)
21. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis.
Moura RA; Canhão H; Polido-Pereira J; Rodrigues AM; Navalho M; Mourão AF; Resende C; Campanilho-Marques R; Madruga Dias J; da Silva JA; Graca L; Fonseca JE
J Rheumatol; 2013 Aug; 40(8):1293-302. PubMed ID: 23772083
[TBL] [Abstract][Full Text] [Related]
22. Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.
Palanichamy A; Muhammad K; Roll P; Kleinert S; Dörner T; Tony HP
J Rheumatol; 2012 Jun; 39(6):1130-8. PubMed ID: 22505705
[TBL] [Abstract][Full Text] [Related]
23. Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis.
Roll P; Mahmood Z; Muhammad K; Feuchtenberger M; Dörner T; Tony HP
Clin Exp Rheumatol; 2015; 33(3):347-53. PubMed ID: 25897997
[TBL] [Abstract][Full Text] [Related]
24. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
[TBL] [Abstract][Full Text] [Related]
25. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
Szodoray P; Alex P; Dandapani V; Nakken B; Pesina J; Kim X; Wallis GL; Wilson PC; Jonsson R; Centola M
Scand J Immunol; 2004; 60(1-2):209-18. PubMed ID: 15238091
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.
Trouvin AP; Jacquot S; Grigioni S; Curis E; Dedreux I; Roucheux A; Boulard H; Vittecoq O; Le Loët X; Boyer O; Goëb V
Clin Exp Immunol; 2015 Apr; 180(1):11-8. PubMed ID: 25370437
[TBL] [Abstract][Full Text] [Related]
27. RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition.
Roll P; Muhammad K; Schumann M; Kleinert S; Tony HP
Scand J Rheumatol; 2012 May; 41(3):180-5. PubMed ID: 22400711
[TBL] [Abstract][Full Text] [Related]
28. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
Pontarini E; Fabris M; Quartuccio L; Cappeletti M; Calcaterra F; Roberto A; Curcio F; Mavilio D; Della Bella S; De Vita S
Rheumatology (Oxford); 2015 Aug; 54(8):1429-34. PubMed ID: 25740829
[TBL] [Abstract][Full Text] [Related]
29. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Ann Rheum Dis; 2007 May; 66(5):700-3. PubMed ID: 17040963
[TBL] [Abstract][Full Text] [Related]
30. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.
Bosello S; Youinou P; Daridon C; Tolusso B; Bendaoud B; Pietrapertosa D; Morelli A; Ferraccioli G
J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969
[TBL] [Abstract][Full Text] [Related]
31. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
[TBL] [Abstract][Full Text] [Related]
32. Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients.
Ruyssen-Witrand A; Rouanet S; Combe B; Dougados M; Le Loët X; Sibilia J; Tebib J; Mariette X; Constantin A
Rheumatology (Oxford); 2013 Apr; 52(4):636-41. PubMed ID: 23264555
[TBL] [Abstract][Full Text] [Related]
33. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
34. Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis.
Toubi E; Kessel A; Slobodin G; Boulman N; Pavlotzky E; Zisman D; Rozenbaum M; Rosner I
Ann Rheum Dis; 2007 Jun; 66(6):818-20. PubMed ID: 17148544
[TBL] [Abstract][Full Text] [Related]
35. Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis.
Nakajima K; Itoh K; Nagatani K; Okawa-Takatsuji M; Fujii T; Kuroki H; Katsuragawa Y; Aotsuka S; Mimori A
Scand J Rheumatol; 2007; 36(5):365-72. PubMed ID: 17963166
[TBL] [Abstract][Full Text] [Related]
36. B-cell activating factor levels in rheumatoid arthritis patients in response to treatment with biologics.
Pyrpasopoulou A; Balaska E; Triantafyllou A; Anyfanti P; Aslanidis S; Douma S
J Interferon Cytokine Res; 2012 Jul; 32(7):338-40. PubMed ID: 22509979
[TBL] [Abstract][Full Text] [Related]
37. Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters.
McComish J; Mundy J; Sullivan T; Proudman SM; Hissaria P
Int J Rheum Dis; 2015 May; 18(4):421-32. PubMed ID: 24589014
[TBL] [Abstract][Full Text] [Related]
38. Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment.
Muhammad K; Roll P; Einsele H; Dörner T; Tony HP
Arthritis Rheum; 2009 Aug; 60(8):2284-93. PubMed ID: 19644860
[TBL] [Abstract][Full Text] [Related]
39. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.
Souto-Carneiro MM; Mahadevan V; Takada K; Fritsch-Stork R; Nanki T; Brown M; Fleisher TA; Wilson M; Goldbach-Mansky R; Lipsky PE
Arthritis Res Ther; 2009; 11(3):R84. PubMed ID: 19500335
[TBL] [Abstract][Full Text] [Related]
40. Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.
Adlowitz DG; Barnard J; Biear JN; Cistrone C; Owen T; Wang W; Palanichamy A; Ezealah E; Campbell D; Wei C; Looney RJ; Sanz I; Anolik JH
PLoS One; 2015; 10(6):e0128269. PubMed ID: 26047509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
